Authors
David S Fink, Julia P Schleimer, Aaron Sarvet, Kiran K Grover, Chris Delcher, Alvaro Castillo-Carniglia, June H Kim, Ariadne E Rivera-Aguirre, Stephen G Henry, Silvia S Martins, Magdalena Cerdá
Publication date
2018/6/5
Source
Annals of internal medicine
Volume
168
Issue
11
Pages
783-790
Publisher
American College of Physicians
Description
Background
Prescription drug monitoring programs (PDMPs) are a key component of the president's Prescription Drug Abuse Prevention Plan to prevent opioid overdoses in the United States.
Purpose
To examine whether PDMP implementation is associated with changes in nonfatal and fatal overdoses; identify features of programs differentially associated with those outcomes; and investigate any potential unintended consequences of the programs.
Data Sources
Eligible publications from MEDLINE, Current Contents Connect (Clarivate Analytics), Science Citation Index (Clarivate Analytics), Social Sciences Citation Index (Clarivate Analytics), and ProQuest Dissertations indexed through 27 December 2017 and additional studies from reference lists.
Study Selection
Observational studies (published in …
Scholar articles
DS Fink, JP Schleimer, A Sarvet, KK Grover, C Delcher… - Annals of internal medicine, 2018